Insulin Glargine (Insulin glargine)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceInsulin GlargineInsulin Glargine
Similar drugsTo uncover
  • Insulin Glargine
    solution PC 
    Sanofi-Aventis Deutschland GmbH     Germany
  • Insulin Glargine
    solution PC 
    ENDODZHENIKS, LLC     Russia
  • Insulin Glargine
    solution PC 
    ProfitMed, CJSC     Russia
  • Lantus® SoloStar®
    solution PC 
    Sanofi-Aventis Deutschland GmbH     Germany
  • Tudzheo SoloStar®
    solution PC 
    Sanofi-Aventis Deutschland GmbH     Germany
    • Dosage form: & nbsphypodermic solution
    ATX: & nbsp

    A.10.A.E.04   Insulin Glargine

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004709
    Date of registration:19.02.2018
    Expiration Date:19.02.2023
    The owner of the registration certificate:ProfitMed, CJSCProfitMed, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp09.04.2018
    Illustrated instructions
      Instructions
      Up
      talkdrugs

      +8 (800)555-35-35

      [email protected]

      The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

      The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

      It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

      All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.